Medicine and Dentistry
Patient
100%
Myeloproliferative Neoplasm
32%
Therapeutic Procedure
30%
Inpatient
30%
Thrombosis
27%
Phlebothrombosis
24%
Venous Thromboembolism
22%
Polycythemia vera
21%
Myelofibrosis
20%
Essential Thrombocythaemia
20%
Combination Therapy
18%
Diagnosis
18%
Platelet
15%
Pregnancy
15%
Thrombophilia
10%
Incidence
10%
Acetylsalicylic Acid
10%
Woman
10%
Myeloproliferative Disorder
10%
Antithrombotic
10%
Prophylaxis
9%
Budd-Chiari Syndrome
9%
Vitamin K Antagonist
9%
Multiple Myeloma
8%
Complication
8%
Diseases
8%
Hydroxyurea
8%
Blood
8%
Neoplasm
7%
Follow up
7%
Second Cancer
7%
Recurrent Disease
7%
Age
7%
Acute Coronary Syndrome
6%
Drug
6%
Chemotherapeutic Agent
6%
Bleeding
5%
Anticoagulation
5%
Gene
5%
Acute Leukemia
5%
Prothrombin G20210A
5%
Spliceosome
5%
Epigenomics
5%
Artery Thrombosis
5%
Donor
5%
Bone Marrow
5%
Observational Study
5%
Low Molecular Weight Heparin
5%
Ruxolitinib
5%
Retrospective Study
5%
Pharmacology, Toxicology and Pharmaceutical Science
Venous Thromboembolism
18%
Thrombosis
15%
Thrombocythemia
13%
Polycythemia vera
11%
Myelofibrosis
10%
Liver Cirrhosis
9%
Myeloproliferative Neoplasm
8%
Incidence
8%
Vein Thrombosis
7%
Portal Vein Thrombosis
7%
Heparin
6%
Acetylsalicylic Acid
6%
Lymphoma
5%
Fondaparinux
5%
Antivitamin K
5%
Anticoagulant Agent
5%